The Chinese firm has pulled back the curtain to expose how the top labs may be building their next-generation models. Now ...

For a slew of AI chip companies chomping to dethrone Nvidia, DeepSeek is the opening they’ve been waiting for.

This new approach, based on natural selection, dramatically improves the reliability of large language models for practical ...

In his new book, LinkedIn's Reid Hoffman argues that fear-focused responses to AI ignore the incredible promise this technological revolution holds.

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

The persistent challenge of AI hallucinations - where artificial intelligence systems generate false or misleading ...

A demo car ad created with Veo 2 from Google DeepMind is so realistic that it's hard to spot the amazing locations, intriguing people and fast cars are all AI.

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Voice deepfakes are making it increasingly hard to figure out if there’s a real person or a bot on the other end of the line.

Combined with the cheap valuations, the robust profitability/rich balance sheet, and DeepMind's leadership in the AI industry, we are reiterating our Buy rating for GOOG stock here. Do not miss ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.